Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components
- 31 August 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (9) , 1334-1340
- https://doi.org/10.1016/s0959-8049(98)00151-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Epitopes of Components of the Plasminogen Activation System are Re-exposed in Formalin-fixed Paraffin Sections by Different Retrieval TechniquesJournal of Histochemistry & Cytochemistry, 1998
- Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): Report of an EORTC/BIOMED-1 WorkshopEuropean Journal Of Cancer, 1996
- Quality control in quantitation of components of the plasminogen activator system in tumour extractsFibrinolysis, 1996
- The Plasminogen Activation System in Tumour Invasion and MetastasisPathology - Research and Practice, 1996
- Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomasBritish Journal of Cancer, 1994
- Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.The Journal of cell biology, 1991
- Clinical Relevance of the Urokinase-Type and Tissue-Type Plasminogen Activators and of Their Type 1 Inhibitor in Breast CancerSeminars in Thrombosis and Hemostasis, 1991
- Effects of formaldehyde fixation on protein secondary structure: a calorimetric and infrared spectroscopic investigation.Journal of Histochemistry & Cytochemistry, 1991
- Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancerFibrinolysis, 1990
- Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary reportCancer, 1988